Full Transcript: INmune Bio Q2 2026 Earnings Call
INmune Bio (NASDAQ: INMB ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary INmune Bio's net loss for Q2 2026 was reduced to $1.3 m